Editorials news and information

Dr. Donald Berwick, a former CMS chief, likes to remind people he is an advocate and wants to pursue his agenda as a candidate for governor of Massachusetts. He might add the title of preacher, too.
FULL STORY »

Nearly a decade ago, the first-year growing pains of the Medicare drug benefit drew a heated yet largely supportive political response.
FULL STORY »

The first-year results from Medicare's Pioneer ACO pilot project showed all 32 of the provider participants met their quality improvement-reporting goals, but only 13 reduced costs.
FULL STORY »

The Obama administration's one-year delay in the employer mandate continues to generate confused and contradictory responses that ignore the collapse of the employer-based insurance system.
FULL STORY »

On a recent business trip, I grabbed a copy of the in-flight magazine and was surprised by a tease on the cover for an article inside: “ADHD in Adults.”
FULL STORY »

The public's love affair with advanced medical technology shows no signs of abating. When it comes to deploying advanced technology, it's easy to convince the average American.
FULL STORY »

“The Federal Trade Commission has been battling for years to end a devious tactic used by some drug companies to pay competitors to delay putting cheaper generic versions of their brand-name drugs on the market. The tactic, known as pay-for-delay, results in higher costs for consumers.
FULL STORY »

The era of big data is approaching. It's hard to overestimate its potential for revolutionizing the practice of medicine.
FULL STORY »

As it gets closer to the launch of the insurance expansion under healthcare reform, the voices of doom grow louder.
FULL STORY »

It took the U.S. 8½ years to land a man on the moon but it will take more than a dozen years to accomplish the task of being able to electronically trace fake or tainted drugs back to their source.
FULL STORY »